Iovance Biotherapeutics, Inc. (IOVA)
3.86
+0.07
(+1.85%)
USD |
NASDAQ |
Feb 27, 16:00
3.83
-0.03
(-0.78%)
After-Hours: 20:00
Iovance Biotherapeutics EPS Diluted (Quarterly) : -0.1767 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Orthofix Medical, Inc. | -0.0555 |
| InfuSystem Holdings, Inc. | 0.0966 |
| Axogen, Inc. | -0.2803 |
| KalVista Pharmaceuticals, Inc. | -0.9183 |
| Lantheus Holdings, Inc. | 0.82 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -71.90M |
| Revenue (Quarterly) | 86.71M |
| Total Expenses (Quarterly) | 158.62M |
| Enterprise Value | 1.285B |
| Gross Profit Margin (Quarterly) | 39.31% |
| Profit Margin (Quarterly) | -82.92% |
| Earnings Yield | -29.04% |
| Normalized Earnings Yield | -28.78 |